Comerica Bank Has $27.83 Million Position in Option Care Health, Inc. $OPCH

Key Points

• Comerica Bank reduced its ownership in Option Care Health, Inc. by 41.4%, now holding approximately $27.83 million worth of shares.
• Institutional investors and hedge funds own a significant 98.05% of Option Care Health's stock, indicating strong institutional interest in the company.
• Option Care Health reported a 15.4% increase in quarterly revenue year-over-year, contributing to a net margin of 3.93% and a return on equity of 17.53%.

Comerica Bank lowered its position in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 41.4% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 796,245 shares of the company's stock after selling 561,383 shares during the period. Comerica Bank owned 0.49% of Option Care Health worth $27,829,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Walleye Trading LLC increased its holdings in Option Care Health by 19.0% in the first quarter. Walleye Trading LLC now owns 30,915 shares of the company's stock worth $1,080,000 after buying an additional 4,946 shares during the last quarter. Walleye Capital LLC acquired a new position in Option Care Health in the first quarter worth approximately $6,264,000. Axiom Investors LLC DE increased its holdings in Option Care Health by 111.2% in the first quarter. Axiom Investors LLC DE now owns 361,615 shares of the company's stock worth $12,638,000 after buying an additional 190,417 shares during the last quarter. Northwestern Mutual Wealth Management Co. increased its holdings in Option Care Health by 1,492.9% in the first quarter. Northwestern Mutual Wealth Management Co. now owns 892 shares of the company's stock worth $31,000 after buying an additional 836 shares during the last quarter. Finally, Advantage Alpha Capital Partners LP increased its holdings in Option Care Health by 78.7% in the first quarter. Advantage Alpha Capital Partners LP now owns 214,619 shares of the company's stock worth $7,501,000 after buying an additional 94,528 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Option Care Health Stock Up 3.2%

Shares of OPCH stock opened at $28.74 on Monday. The stock has a market cap of $4.66 billion, a P/E ratio of 22.99, a price-to-earnings-growth ratio of 1.75 and a beta of 0.79. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The stock has a fifty day moving average price of $29.92 and a 200 day moving average price of $31.76. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.40 by $0.01. The firm had revenue of $1.42 billion during the quarter, compared to analysts' expectations of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.Option Care Health's quarterly revenue was up 15.4% compared to the same quarter last year. During the same period last year, the business earned $0.30 earnings per share. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. Analysts predict that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Insider Buying and Selling at Option Care Health

In related news, Director Timothy P. Sullivan acquired 20,000 shares of the company's stock in a transaction on Thursday, August 21st. The stock was purchased at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the completion of the purchase, the director directly owned 49,229 shares of the company's stock, valued at $1,354,289.79. The trade was a 68.43% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. acquired 36,000 shares of the company's stock in a transaction on Wednesday, August 20th. The shares were bought at an average price of $27.15 per share, with a total value of $977,400.00. Following the completion of the purchase, the director directly owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. This represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. 0.64% of the stock is owned by company insiders.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on OPCH shares. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Thursday, July 10th. Citigroup reaffirmed an "outperform" rating on shares of Option Care Health in a research report on Thursday, July 31st. JMP Securities upped their target price on Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a research report on Thursday, July 31st. Finally, UBS Group raised Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $38.00 to $40.00 in a research report on Wednesday, April 30th. Eight analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.